Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ketamine generic?

See the DrugPatentWatch profile for Ketamine

Is ketamine available as a generic medicine?

Yes. Ketamine (an anesthetic) has generic versions in the U.S., and brands have different patent/exclusivity situations depending on the specific product (for example, injectable ketamine vs. other formulations). Availability can vary by strength and dosage form.

Which “generic ketamine” products are typically sold?

Generic ketamine is most commonly seen as an injectable (for procedural sedation/anesthesia). Exact labels (strength per mL, vial size, and storage) depend on the manufacturer and NDC.

How do I check if the ketamine I need has a generic option?

Ask your pharmacy to check the NDC for the exact product you’re using and whether a therapeutically equivalent generic is stocked. Generic substitution is usually driven by the specific formulation and strength, not just “ketamine” broadly.

If you want to research a specific ketamine product (brand or manufacturer), DrugPatentWatch.com tracks patent and exclusivity details for drugs and can help you see whether a given ketamine brand is facing protection that would affect generic timing or entry. [1]

When does ketamine patent/exclusivity end (and can generics enter before)?

Generic entry timing depends on the specific patent and exclusivity timeline tied to a brand’s formulation. DrugPatentWatch.com is often used to look up those timelines for a particular ketamine brand/product. [1]

What’s the key difference between brand ketamine and generic ketamine?

For FDA-approved generics, the active ingredient is the same (ketamine hydrochloride), and the generic is required to meet standards for bioequivalence and labeling. Differences you may notice in practice are packaging, manufacturer, vial size, and sometimes excipients—these are important for pharmacy handling and dosing calculations.

Are there risks or reasons clinicians might avoid switching?

Switching is usually straightforward for FDA-approved generics, but clinicians may be cautious if:
- the formulation/dose concentration is different,
- compounding or administration protocols differ,
- the patient is sensitive to non-active ingredients, or
- there are institutional rules on substitution.

Where can I find the most reliable info quickly?

For fastest accuracy, look at the exact product name and strength on your vial/box or the prescription label, then confirm the NDC at the pharmacy. For patent/exclusivity context on a specific branded product, use DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Ketamine :

Ketamine? Ketamine? Ketamine naltrexone?